Chiesi Enters Poland’s OTC Market With Smart Pharma Buy
Executive Summary
Italy's Chiesi is looking to take a slice of Poland's consumer healthcare market by acquiring infant supplements specialist Smart Pharma.
You may also be interested in...
People On The Move: Appointments At Perrigo, Chiesi, Haleon, HMPC
A round-up of the latest European consumer health industry appointments: Perrigo makes changes to DACH management; Chiesi appoints Giuseppe Accogli as CEO; Haleon adds Pfizer's David Denton to its board; and EMA's Committee on Herbal Medicinal Products re-elects Emiel Van Galen as its chair.
Poland Gives Green Light To Switches From Teva and Polpharma
Teva and Polpharma's OTC operations in Poland are set to received a boost with the approval of two switches by national medicines regulator URPL. Polish consumers can now get OTC access to additional treatments for hay fever and cough.
Poland Switches from Rx-To-OTC Mylan's Duspatalin For IBS, Plus Orion's ED Treatment
Poland's medicines regulator has approved the switch of Mylan's Duspatalin and Orion's Valinger.